Thermo Fisher Scientific Q3 FY26: where the revenue came from and where it went
The whole income statement of Thermo Fisher Scientific for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 28 – Sep 26, 2026
- Reported
- Oct 30, 2026
Revenue$12.14B
+9% year over year
Gross profit$4.89B
40% margin
Operating profit$2.26B
19% margin
Net profit$1.72B
14% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 12.14 | 100% | +9% |
| Services | 5.38 | 44% | +16% |
| Product consumables | 4.87 | 40% | |
| Product instruments | 1.88 | 16% | |
| Cost of revenue | −7.25 | 60% | |
| Gross profit | 4.89 | 40% margin | +0pp |
| R&D | −0.35 | 3% | +0pp |
| SG&A | −2.28 | 19% | +0pp |
| Operating profit | 2.26 | 19% margin | +1pp |
| Interest & other costs | −0.19 | ||
| Tax | −0.35 | ||
| Net profit | 1.72 | 14% margin |
3 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest